4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 23, 2023 15:30 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 17, 2023 14:51 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 7, 2023 15:17 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Jan 3, 2023 12:09 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Nov 18, 2022 14:58 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Nov 15, 2022 13:53 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Oct 7, 2022 10:58 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Sep 30, 2022 15:04 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Aug 24, 2022 17:06 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Aug 24, 2022 16:56 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Aug 24, 2022 16:43 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Jul 5, 2022 14:06 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Jun 29, 2022 14:25 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Jun 24, 2022 17:19 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Jun 24, 2022 09:19 ET
4D pharma | F-3: Registration statement for specified transactions by certain foreign private issuers
Apr 21, 2022 16:29 ET
4D pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Apr 1, 2022 16:44 ET
4D pharma | F-3/A: Registration statement for specified transactions by certain foreign private issuers (Amendment)
Mar 28, 2022 17:28 ET
4D pharma | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 23, 2022 07:45 ET
4D pharma | F-3: Registration statement for specified transactions by certain foreign private issuers
Mar 8, 2022 17:09 ET
No Data
No Data